138 related articles for article (PubMed ID: 38259164)
1. The added value of radiomics in determining patient responsiveness to laryngeal preservation strategies.
Ravanelli M; Rondi P; Di Meo N; Farina D
Curr Opin Otolaryngol Head Neck Surg; 2024 Apr; 32(2):134-137. PubMed ID: 38259164
[TBL] [Abstract][Full Text] [Related]
2. The application of radiomics in laryngeal cancer.
Rajgor AD; Patel S; McCulloch D; Obara B; Bacardit J; McQueen A; Aboagye E; Ali T; O'Hara J; Hamilton DW
Br J Radiol; 2021 Dec; 94(1128):20210499. PubMed ID: 34586899
[TBL] [Abstract][Full Text] [Related]
3. Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
Forastiere AA; Ismaila N; Lewin JS; Nathan CA; Adelstein DJ; Eisbruch A; Fass G; Fisher SG; Laurie SA; Le QT; O'Malley B; Mendenhall WM; Patel S; Pfister DG; Provenzano AF; Weber R; Weinstein GS; Wolf GT
J Clin Oncol; 2018 Apr; 36(11):1143-1169. PubMed ID: 29172863
[TBL] [Abstract][Full Text] [Related]
4. Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study.
Mesía R; Garcia-Saenz JA; Lozano A; Pastor M; Grau JJ; Martínez-Trufero J; Lambeaz J; Martínez-Galán J; Mel JR; González B; Vázquez S; Mañós M; Taberna M; Cirauqui B; Del Barco E; Casado E; Rubió-Casadevall J; Rodríguez-Jaráiz A; Cruz JJ;
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):473-480. PubMed ID: 28011050
[TBL] [Abstract][Full Text] [Related]
5. Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer.
Guadagnolo BA; Haddad RI; Posner MR; Weeks L; Wirth LJ; Norris CM; Sullivan CA; Goguen L; Busse PM; Tishler R
Am J Clin Oncol; 2005 Aug; 28(4):371-8. PubMed ID: 16062079
[TBL] [Abstract][Full Text] [Related]
6. Organ preservation for advanced larynx cancer: A review of chemotherapy and radiation combination strategies.
Bonomi MR; Blakaj A; Blakaj D
Oral Oncol; 2018 Nov; 86():301-306. PubMed ID: 30409316
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer.
Kamal M; Ng SP; Eraj SA; Rock CD; Pham B; Messer JA; Garden AS; Morrison WH; Phan J; Frank SJ; El-Naggar AK; Johnson JM; Ginsberg LE; Ferrarotto R; Lewin JS; Hutcheson KA; Cardenas CE; Zafereo ME; Lai SY; Hessel AC; Weber RS; Gunn GB; Fuller CD; Mohamed ASR; Rosenthal DI
Oral Oncol; 2018 Apr; 79():1-8. PubMed ID: 29598944
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of current and emerging approaches in the field of larynx preservation.
Denaro N; Russi EG; Lefebvre JL; Merlano MC
Radiother Oncol; 2014 Jan; 110(1):16-24. PubMed ID: 24139733
[TBL] [Abstract][Full Text] [Related]
9. Radiomics and Texture Analysis in Laryngeal Cancer. Looking for New Frontiers in Precision Medicine through Imaging Analysis.
Chiesa-Estomba CM; Echaniz O; Larruscain E; Gonzalez-Garcia JA; Sistiaga-Suarez JA; Graña M
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31547210
[TBL] [Abstract][Full Text] [Related]
10. [Radiomics nomogram of MR: a prediction of cervical lymph node metastasis in laryngeal cancer].
Jia CL; Cao Y; Song Q; Zhang WB; Li JJ; Wu XX; Yu PY; Mou YK; Mao N; Song XC
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Dec; 55(12):1154-1161. PubMed ID: 33342131
[No Abstract] [Full Text] [Related]
11. Induction chemotherapy followed by radiotherapy for larynx preservation in advanced laryngeal and hypopharyngeal cancer: Outcome prediction after one cycle induction chemotherapy by a score based on clinical evaluation, computed tomography-based volumetry and
Wichmann G; Krüger A; Boehm A; Kolb M; Hofer M; Fischer M; Müller S; Purz S; Stumpp P; Sabri O; Dietz A; Kluge R
Eur J Cancer; 2017 Feb; 72():144-155. PubMed ID: 28033526
[TBL] [Abstract][Full Text] [Related]
12. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
[TBL] [Abstract][Full Text] [Related]
13. Non-surgical organ preservation strategies for locally advanced laryngeal tumors: what is the Italian attitude? Results of a national survey on behalf of AIRO and AIOM.
Alterio D; Franco P; Numico G; Licitra L; Cossu Rocca M; Ferrari A; Pinto C; Russi EG; Ricardi U; Jereczek Fossa BA
Med Oncol; 2016 Jul; 33(7):76. PubMed ID: 27290695
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of CT-based radiomics signature and nomogram as prognostic markers in patients with laryngeal squamous cell carcinoma.
Chen L; Wang H; Zeng H; Zhang Y; Ma X
Cancer Imaging; 2020 Apr; 20(1):28. PubMed ID: 32321585
[TBL] [Abstract][Full Text] [Related]
15. Treatment results of alternating chemoradiotherapy with early assessment for advanced laryngeal cancer: A multi-institutional phase II study.
Nakata Y; Ijichi K; Hanai N; Nishikawa D; Suzuki H; Hirakawa H; Kodaira T; Fujimoto Y; Fujii T; Miyazaki T; Shimizu T; Hasegawa Y
Auris Nasus Larynx; 2017 Feb; 44(1):104-110. PubMed ID: 27435048
[TBL] [Abstract][Full Text] [Related]
16. Radiomics: a quantitative imaging biomarker in precision oncology.
Jha AK; Mithun S; Purandare NC; Kumar R; Rangarajan V; Wee L; Dekker A
Nucl Med Commun; 2022 May; 43(5):483-493. PubMed ID: 35131965
[TBL] [Abstract][Full Text] [Related]
17. Advanced carcinoma of the larynx: results of surgery and radiotherapy without induction chemotherapy (1980-1985): a multivariate analysis.
Nguyen TD; Malissard L; Théobald S; Eschwège F; Panis X; Bachaud JM; Rambert P; Chaplain G; Quint R
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1013-8. PubMed ID: 8985021
[TBL] [Abstract][Full Text] [Related]
18. Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II.
Dietz A; Wichmann G; Kuhnt T; Pfreundner L; Hagen R; Scheich M; Kölbl O; Hautmann MG; Strutz J; Schreiber F; Bockmühl U; Schilling V; Feyer P; de Wit M; Maschmeyer G; Jungehülsing M; Schroeder U; Wollenberg B; Sittel C; Münter M; Lenarz T; Klussmann JP; Guntinas-Lichius O; Rudack C; Eich HT; Foerg T; Preyer S; Westhofen M; Welkoborsky HJ; Esser D; Thurnher D; Remmert S; Sudhoff H; Görner M; Bünzel J; Budach V; Held S; Knödler M; Lordick F; Wiegand S; Vogel K; Boehm A; Flentje M; Keilholz U
Ann Oncol; 2018 Oct; 29(10):2105-2114. PubMed ID: 30412221
[TBL] [Abstract][Full Text] [Related]
19. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience.
Shirinian MH; Weber RS; Lippman SM; Dimery IW; Earley CL; Garden AS; Michaelson J; Morrison WH; Kramer A; Byers R
Head Neck; 1994; 16(1):39-44. PubMed ID: 7510276
[TBL] [Abstract][Full Text] [Related]
20. Clinical Utility of Pretreatment and 3-Month
Mayo Z; Seyedin SN; Mallak N; Mott SL; Menda Y; Graham M; Anderson C
Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):595-600. PubMed ID: 30808209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
